Pictet Asset Management Holding SA »

Apellis Pharmaceuticals shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.8M 298k 29.45
2024-03-31 $63M 1.1M 58.73

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Apellis Pharmaceuticals

EcoR1 Capital
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
Deep Track Capital
Logos Global Management
Siren
Assenagon Asset Management
Morgan Stanley
Jennison Associates

View all funds holding Apellis Pharmaceuticals